RNX-041
N/A
Report date: 2023/03/30 14:50:16
Base Information
Drug NameRNX-041
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesReponex Pharmaceuticals As
China Registration ClassN/A
Develop Information
Active CompaniesReponex Pharmaceuticals As
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A